IBDEI0GY ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8199,1,3,0)
 ;;=3^Lacrimal Punctum Stenosis
 ;;^UTILITY(U,$J,358.3,8199,1,4,0)
 ;;=4^375.52
 ;;^UTILITY(U,$J,358.3,8199,2)
 ;;=^269152
 ;;^UTILITY(U,$J,358.3,8200,0)
 ;;=375.55^^52^578^89
 ;;^UTILITY(U,$J,358.3,8200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8200,1,3,0)
 ;;=3^Obstruct Nasolac Duct,Neonat
 ;;^UTILITY(U,$J,358.3,8200,1,4,0)
 ;;=4^375.55
 ;;^UTILITY(U,$J,358.3,8200,2)
 ;;=^269158
 ;;^UTILITY(U,$J,358.3,8201,0)
 ;;=375.61^^52^578^75
 ;;^UTILITY(U,$J,358.3,8201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8201,1,3,0)
 ;;=3^Lacrimal Fistula
 ;;^UTILITY(U,$J,358.3,8201,1,4,0)
 ;;=4^375.61
 ;;^UTILITY(U,$J,358.3,8201,2)
 ;;=^269162
 ;;^UTILITY(U,$J,358.3,8202,0)
 ;;=375.9^^52^578^74
 ;;^UTILITY(U,$J,358.3,8202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8202,1,3,0)
 ;;=3^Lac System,Unspec D/O
 ;;^UTILITY(U,$J,358.3,8202,1,4,0)
 ;;=4^375.9
 ;;^UTILITY(U,$J,358.3,8202,2)
 ;;=^269166
 ;;^UTILITY(U,$J,358.3,8203,0)
 ;;=379.03^^52^578^112
 ;;^UTILITY(U,$J,358.3,8203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8203,1,3,0)
 ;;=3^Scleritis Anterior,NEC
 ;;^UTILITY(U,$J,358.3,8203,1,4,0)
 ;;=4^379.03
 ;;^UTILITY(U,$J,358.3,8203,2)
 ;;=^269287
 ;;^UTILITY(U,$J,358.3,8204,0)
 ;;=379.11^^52^578^115
 ;;^UTILITY(U,$J,358.3,8204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8204,1,3,0)
 ;;=3^Staphyloma,Ectasia
 ;;^UTILITY(U,$J,358.3,8204,1,4,0)
 ;;=4^379.11
 ;;^UTILITY(U,$J,358.3,8204,2)
 ;;=^269298
 ;;^UTILITY(U,$J,358.3,8205,0)
 ;;=743.45^^52^578^5
 ;;^UTILITY(U,$J,358.3,8205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8205,1,3,0)
 ;;=3^Aniridia,Congenital
 ;;^UTILITY(U,$J,358.3,8205,1,4,0)
 ;;=4^743.45
 ;;^UTILITY(U,$J,358.3,8205,2)
 ;;=^7827
 ;;^UTILITY(U,$J,358.3,8206,0)
 ;;=743.65^^52^578^114
 ;;^UTILITY(U,$J,358.3,8206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8206,1,3,0)
 ;;=3^Specified Congen Anomalies
 ;;^UTILITY(U,$J,358.3,8206,1,4,0)
 ;;=4^743.65
 ;;^UTILITY(U,$J,358.3,8206,2)
 ;;=^272847
 ;;^UTILITY(U,$J,358.3,8207,0)
 ;;=771.6^^52^578^85
 ;;^UTILITY(U,$J,358.3,8207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8207,1,3,0)
 ;;=3^Neonatal Dacryocystitis
 ;;^UTILITY(U,$J,358.3,8207,1,4,0)
 ;;=4^771.6
 ;;^UTILITY(U,$J,358.3,8207,2)
 ;;=^81904
 ;;^UTILITY(U,$J,358.3,8208,0)
 ;;=375.15^^52^578^36
 ;;^UTILITY(U,$J,358.3,8208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8208,1,3,0)
 ;;=3^Dry Eye
 ;;^UTILITY(U,$J,358.3,8208,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,8208,2)
 ;;=^37168
 ;;^UTILITY(U,$J,358.3,8209,0)
 ;;=379.31^^52^579^1
 ;;^UTILITY(U,$J,358.3,8209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8209,1,3,0)
 ;;=3^Aphakia
 ;;^UTILITY(U,$J,358.3,8209,1,4,0)
 ;;=4^379.31
 ;;^UTILITY(U,$J,358.3,8209,2)
 ;;=^9445
 ;;^UTILITY(U,$J,358.3,8210,0)
 ;;=366.15^^52^579^4
 ;;^UTILITY(U,$J,358.3,8210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8210,1,3,0)
 ;;=3^Cataract, Cortical
 ;;^UTILITY(U,$J,358.3,8210,1,4,0)
 ;;=4^366.15
 ;;^UTILITY(U,$J,358.3,8210,2)
 ;;=Cortical Senile Cataract^268797
 ;;^UTILITY(U,$J,358.3,8211,0)
 ;;=366.16^^52^579^10
 ;;^UTILITY(U,$J,358.3,8211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8211,1,3,0)
 ;;=3^Cataract, Nuclear Sclerosis
 ;;^UTILITY(U,$J,358.3,8211,1,4,0)
 ;;=4^366.16
 ;;^UTILITY(U,$J,358.3,8211,2)
 ;;=366.16^268800
 ;;^UTILITY(U,$J,358.3,8212,0)
 ;;=366.14^^52^579^12
 ;;^UTILITY(U,$J,358.3,8212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8212,1,3,0)
 ;;=3^Cataract, PSC/Post Subcapsular
 ;;^UTILITY(U,$J,358.3,8212,1,4,0)
 ;;=4^366.14
 ;;^UTILITY(U,$J,358.3,8212,2)
 ;;=Post Subcapsular Senile Cataract^268796
 ;;^UTILITY(U,$J,358.3,8213,0)
 ;;=V43.1^^52^579^28
